🔴 Breaking News
5h ago
FDA approves new pancreatic cancer drug that could extend patients' lives
Source ↗
👁 0
💬 0
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
Comments (0)